Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Total Debt (2019 - 2024)

Updated

Pharming (PHAR) recorded Total Debt of $143,000 in Q3 2022, down 5.9% from the prior quarter.

Analysis

Pharming (PHAR) Total Debt (2019 - 2024) Analysis & Trends

At the end of FY2020, Pharming reported Total Debt of $23.24 million, down 69.9% from FY2019.

  • Across earlier years, Total Debt came in at $77.23 million in FY2019.
  • The Q3 2022 figure is the lowest quarterly Total Debt since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.25 Mn
Dec 31, 2023 2.02 Mn
Jun 30, 2023 91,000.00
Dec 31, 2022 2.02 Mn
Sep 30, 2022 143,000.00
Jun 30, 2022 152,000.00
Mar 31, 2022 162,000.00
Sep 30, 2021 386,000.00
Jun 30, 2021 189,240.66
Mar 31, 2021 188,750.03
Dec 31, 2020 25.04 Mn
Dec 31, 2019 77.25 Mn
API Access

Pharming Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEY